Filing Flows › Immucell (ICCC) › How it makes money
How Immucell (ICCC) makes money
Immucell (ICCC) made $7.2M of revenue in the second quarter 2026 (Q2 2026), +12% from a year earlier. Of every dollar of revenue, 34¢ was left as gross profit, 27¢ was left as operating profit, 26¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $7.2M | 100.0% |
| Cost of revenue | $4.7M | 66.1% |
| Gross profit | $2.4M | 33.9% |
| Operating expenses | $502K | 7.0% |
| Operating profit | $1.9M | 26.9% |
| Income tax | $46K | 0.6% |
| Net earnings | $1.8M | 25.5% |
| Operating cash flow | $3.0M | 42.0% |
| Free cash flow | $2.3M | 31.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $7.2M | +12% |
| Q1 2026 | $10.4M | +28% |
| Q4 2025 | $7.6M | -2% |
| Q3 2025 | $5.5M | -8% |
| Q2 2025 | $6.4M | +18% |
| Q1 2025 | $8.1M | +11% |
| Q4 2024 | $7.8M | +52% |
From Immucell's 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Immucell make money?
Immucell (ICCC) made $7.2M of revenue in the second quarter 2026 (Q2 2026), +12% from a year earlier. Of every dollar of revenue, 34¢ was left as gross profit, 27¢ was left as operating profit, 26¢ was left as net earnings.
What is Immucell's profit margin?
Net earnings were $1.8M, 25.5% of revenue, in the second quarter 2026; the operating margin was 26.9%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.